Literature DB >> 27046394

Psychosocial functioning, quality of life and clinical correlates of comorbid alcohol and drug dependence syndromes in people with schizophrenia across Europe.

Giuseppe Carrà1, Sonia Johnson2, Cristina Crocamo3, Matthias C Angermeyer4, Traolach Brugha5, Jean-Michel Azorin6, Mondher Toumi7, Paul E Bebbington8.   

Abstract

Little is known about the correlates of comorbid drug and alcohol dependence in people with schizophrenia outside the USA. We tested hypotheses that dependence on alcohol/drugs would be associated with more severe symptoms, and poorer psychosocial functioning and quality of life. The EuroSC Cohort study (N=1204), based in France, Germany and the UK, used semi-structured clinical interviews for diagnoses, and standardized tools to assess correlates. We used mixed models to compare outcomes between past-year comorbid dependence on alcohol/drugs, controlling for covariates and modelling both subject and country-level effects. Participants dependent on alcohol or drugs had fewer negative symptoms on PANSS than their non-dependent counterparts. However, those dependent on alcohol scored higher on PANSS general psychopathology than those who were not, or dependent only on drugs. People with schizophrenia dependent on drugs had poorer quality of life, more extrapyramidal side effects, and scored worse on Global Assessment of Functioning (GAF) than those without dependence. People with alcohol dependence reported more reasons for non-compliance with medication, and poorer functioning on GAF, though not on Global Assessment of Relational Functioning. In people with schizophrenia, comorbid dependence on alcohol or drugs is associated with impaired clinical and psychosocial adjustment, and poorer quality of life.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alcohol dependence; Comorbidity; Drug dependence; Schizophrenia

Mesh:

Year:  2016        PMID: 27046394     DOI: 10.1016/j.psychres.2016.03.038

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  15 in total

1.  Clozapine and Psychosocial Function in Schizophrenia: A Systematic Review and Meta-Analysis.

Authors:  Andrew T Olagunju; Scott R Clark; Bernhard T Baune
Journal:  CNS Drugs       Date:  2018-11       Impact factor: 5.749

2.  Latent Psychotic Symptom Profiles Amongst People Who Use Methamphetamine: What Do They Tell Us About Existing Diagnostic Categories?

Authors:  Rebecca McKetin; Alexandra Voce; Richard Burns; Robert Ali; Dan I Lubman; Amanda L Baker; David J Castle
Journal:  Front Psychiatry       Date:  2018-11-19       Impact factor: 4.157

3.  Comorbid opioid use is undertreated among forensic patients with schizophrenia.

Authors:  Kristiina Kivimies; Eila Repo-Tiihonen; Hannu Kautiainen; Jari Tiihonen
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-11-06

4.  Analysis of psychotropic drug-related deaths in south Osaka.

Authors:  Naoto Tani; Tomoya Ikeda; Tomomi Michiue; Shigeki Oritani; Fumiya Morioka; Takaki Ishikawa
Journal:  Subst Abuse Rehabil       Date:  2018-09-24

5.  Helpful Ingredients in the Treatment of Long-Term Substance Use Disorders: A Collaborative Narrative Study.

Authors:  Henning Pettersen; Anne Landheim; Ivar Skeie; Stian Biong; Morten Brodahl; Victoria Benson; Larry Davidson
Journal:  Subst Abuse       Date:  2019-04-26

6.  Identification of 34 genes conferring genetic and pharmacological risk for the comorbidity of schizophrenia and smoking behaviors.

Authors:  Yunlong Ma; Jingjing Li; Yi Xu; Yan Wang; Yinghao Yao; Qiang Liu; Maiqiu Wang; Xinyi Zhao; Rongli Fan; Jiali Chen; Bin Zhang; Zhen Cai; Haijun Han; Zhongli Yang; Wenji Yuan; Yigang Zhong; Xiangning Chen; Jennie Z Ma; Thomas J Payne; Yizhou Xu; Yuping Ning; Wenyan Cui; Ming D Li
Journal:  Aging (Albany NY)       Date:  2020-02-03       Impact factor: 5.682

7.  Prevalence of Coaddictions and Rate of Successful Treatment Among a French Sample of Opioid-Dependent Patients With Long-Term Opioid Substitution Therapy: The OPAL Study.

Authors:  Marie Grall-Bronnec; Edouard-Jules Laforgue; Gaëlle Challet-Bouju; Jennyfer Cholet; Jean-Benoit Hardouin; Juliette Leboucher; Morgane Guillou-Landréat; Caroline Victorri-Vigneau
Journal:  Front Psychiatry       Date:  2019-10-17       Impact factor: 4.157

Review 8.  Catechol-O-methyltransferase (COMT) Val158Met Polymorphism and Susceptibility to Alcohol Dependence.

Authors:  Amrita Chaudhary; Pradeep Kumar; Vandana Rai
Journal:  Indian J Clin Biochem       Date:  2021-01-02

9.  A Meta-Analysis of the Efficacy of Case Management for Substance Use Disorders: A Recovery Perspective.

Authors:  Wouter Vanderplasschen; Richard C Rapp; Jessica De Maeyer; Wim Van Den Noortgate
Journal:  Front Psychiatry       Date:  2019-04-16       Impact factor: 4.157

10.  "A Life More Ordinary" Processes of 5-Year Recovery From Substance Abuse. Experiences of 30 Recovered Service Users.

Authors:  Jone Bjornestad; Thomas Solgaard Svendsen; Tale Ekeroth Slyngstad; Aleksander H Erga; James R McKay; Sverre Nesvåg; Alexander Waagan Skaalevik; Marius Veseth; Christian Moltu
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.